Fintel Plc (AIM:FNTL)
207.00
-1.00 (-0.48%)
At close: Dec 5, 2025
Fintel Revenue
Fintel had revenue of 42.40M GBP in the half year ending June 30, 2025, with 33.75% growth. This brings the company's revenue in the last twelve months to 85.00M, up 23.37% year-over-year. In the year 2024, Fintel had annual revenue of 78.30M with 20.65% growth.
Revenue (ttm)
85.00M
Revenue Growth
+23.37%
P/S Ratio
2.54
Revenue / Employee
136.22K
Employees
624
Market Cap
215.68M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 78.30M | 13.40M | 20.65% |
| Dec 31, 2023 | 64.90M | -1.60M | -2.41% |
| Dec 31, 2022 | 66.50M | 2.60M | 4.07% |
| Dec 31, 2021 | 63.90M | 2.90M | 4.75% |
| Dec 31, 2020 | 61.00M | -1.77M | -2.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| International Consolidated Airlines Group | 29.05B |
| BAE Systems | 27.41B |
| Rolls-Royce Holdings | 19.54B |
| RELX PLC | 9.53B |
| Ashtead Group | 8.20B |
| Experian | 5.93B |
| Rentokil Initial | 5.53B |
| Smiths Group | 2.92B |
Fintel News
- 7 days ago - CIBC Upgrades Canadian National Railway (CNI) - Nasdaq
- 7 days ago - HC Wainwright & Co. Reiterates Halozyme Therapeutics (HALO) Buy Recommendation - Nasdaq
- 7 days ago - HC Wainwright & Co. Reiterates Anavex Life Sciences (AVXL) Buy Recommendation - Nasdaq
- 15 days ago - Keybanc Maintains NVIDIA (NVDA) Overweight Recommendation - Nasdaq
- 15 days ago - Cantor Fitzgerald Reiterates NVIDIA (NVDA) Overweight Recommendation - Nasdaq
- 15 days ago - Wedbush Maintains NVIDIA (NVDA) Outperform Recommendation - Nasdaq
- 15 days ago - Argus Research Reiterates NVIDIA (NVDA) Buy Recommendation - Nasdaq
- 15 days ago - Baird Maintains NVIDIA (NVDA) Outperform Recommendation - Nasdaq